Modified Banxia Xiexin decoction

{
  "id": "MLC-T-ONC-015222",
  "term": "Modified Banxia Xiexin decoction",
  "field": "Oncology and biomedicine",
  "definition": "A traditional Chinese medicine (TCM) formulation, Banxia Xiexin decoction, composed of seven traditional Chinese herbs including Rhizoma Pinelliae (Ban Xia), Radix Scutellariae (Huang Qin), Rhizome Coptidis (Huang Lian), Rhizoma Zingibers (Gan Jiang), Radix Glycyrrhizae (Gan Cao), Fructus Ziziphi Jujubae (Da Zao), and Radix Ginseng (Ren Shen), modified by various Chinese herbal additions, with potential anti-inflammatory, immunomodulating and antineoplastic activities. Upon administration of modified Banxia Xiexin decoction, the active ingredients may promote apoptosis and inhibit tumor cell proliferation through a not yet fully elucidated mechanism. Modified Banxia Xiexin decoction may also inhibit Helicobacter pylori and H. pylori-related inflammation, and protect the gastric mucosa, which may decrease glandular atrophy, intestinal metaplasia, and dysplasia of the gastric mucosa.",
  "abbreviation": "MBXD",
  "synonyms": [
    "modified BXD"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/modified-banxia-xiexin-decoction/"
}